Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Active, not recruitingOBSERVATIONAL
Enrollment

294

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Renal Cancer
Interventions
BEHAVIORAL

(EORTC QLQ-C30) questionnaire

BEHAVIORAL

EuroQol EQ-5D 7-item questionnaire

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

19107

Thomas Jefferson University Hospital, Philadelphia

21201

University of Maryland Medical Center, Baltimore

77030

Md Anderson Cancer Center, Houston

90095

University of California, Los Angeles, Los Angeles

02903

Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

Barbara Ann Karmanos Cancer Institute

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

University of Maryland, Baltimore County

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

San Diego Imaging Medical Group

UNKNOWN

collaborator

Hospital Sirio-Libanes

OTHER

collaborator

University Hospital, Bordeaux

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER